 |
Articles: Marketing/Media/ROI |
Putting Predictive Market Research to the Test
PharmExec, 04/07/09
Ciba and BASF agree to sell Ciba's CHIMASSORB 119 FL hindered amine light stabilizer business to Sabo S.r.l.
Ciba, 04/06/09
Free full text
Cell Therapeutics Satisfies NASDAQ Listing Requirements to Continue to Trade on NASDAQ Capital Market
Cell Therapeutics, 04/06/09
Free full text
“Steady course for growth in innovative markets”
BayNews International, 04/03/09
Free full text
Ixiaro vaccine receives Marketing Authorization in Europe for the prevention of Japanese Encephalitis
Novartis, 04/03/09
Free full text
Biopure Receives Extension of Time to Regain NASDAQ Listing Compliance
BioPure, 04/02/09
Free full text
Whole Foods Market Issues Nationwide Voluntary Recall of In-Shell Pistachio Nuts Due to Possible Health Risk
FDA Drug Alerts, 04/02/09
Free full text
Medtronic Announces International Market Release of Driver Sprint RX Coronary Stent System
Medtronic, 04/01/09
Free full text
GAO: Largest small group health insurers gaining market share
American Hospital Association News, 03/31/09
Free full text
Companies use MDDexec event to launch products
b3c newswire, 03/27/09 Drug Sales See Minimal Climb in 2008
PharmExec, 03/26/09 Merck and Co., Inc. Provides Update on Previously-Disclosed U.S. Department of Justice Investigation Relating to VIOXX
Merck & Co., 03/24/09
Free full text
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) patches announced
FDA Drug Alerts, 03/24/09
Free full text
Non-safety-related voluntary market withdrawal of a limited portion of DAYTRANA (methylphenidate transdermal system) patches announced
Shire, 03/23/09 Experts unite to create new online resource for Restless Legs Syndrome For medical media, outside the US only
Boehringer Ingelheim, 03/20/09
Free full text
European CHMP Adopts Negative Opinion on Aztreonam Lysine
Gilead, 03/20/09
Free full text
Massachusetts Passes New Sales and Marketing Rules
PharmExec, 03/19/09 Adapt EDC for Postmarket
Applied Clinical Trials, 03/18/09
Free full text
Business and People Update
Applied Clinical Trials, 03/18/09
Free full text
Announced acquisition of EQUASYM IR and XL (methylphenidate hydrochloride) for the treatment of ADHD provides Shire entry to the European ADHD market
Shire, 03/17/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
234 Available Pages
|
|
